Evaluation of hypotensive efficacy, tolerability and safety of Brinzopt carbonohydrase inhibitor in glaucoma therapy and correction of postoperative ophthalmic hypertension in patients with cataract | Erichev | National Journal glaucoma

National Journal glaucoma
Natsional’nyi zhurnal glaukoma

ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)

eng | рус

Preview

National Journal glaucoma

Advanced search

Archives

Download this PDF file

For citations:

Erichev V.P., Kozlova I.V., Makarova A.S., Kosova J.V., Poleva R.P. Evaluation of hypotensive efficacy, tolerability and safety of Brinzopt carbonohydrase inhibitor in glaucoma therapy and correction of postoperative ophthalmic hypertension in patients with cataract. National Journal glaucoma. 2017;16(3):81-88. (In Russ.)

Views PDF (Rus): 559

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Article Tools

Finding References

Email this article (Login required)

About the Authors

V. P. Erichev
Scientific Research Institute of Eye Diseases
Russian Federation

Med.Sc.D., Professor, Deputy Director for Innovative Studies

I. V. Kozlova
Scientific Research Institute of Eye Diseases
Russian Federation

Ph.D., Senior Research Associate of the Glaucoma Department

A. S. Makarova
Scientific Research Institute of Eye Diseases
Russian Federation

Ph.D., Research Associate of the Glaucoma Department

J. V. Kosova
Scientific Research Institute of Eye Diseases
Russian Federation

Postgraduate student of the Glaucoma Department

R. P. Poleva
Scientific Research Institute of Eye Diseases
Russian Federation

Ph.D., Senior Research Associate of the Glaucoma Department

Notifications